Alberto Goday Arno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alberto Goday Arno has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
J. Franch
1 shared publicationJ.F. Ascaso
1 shared publicationJosep Maria Corretger
Down Syndrome Medical Center, Down Syndrome Catalan Foundation, Centre Medic Down de la Fundacio Catalana Sindrome de Down, Barcelona, Spain
1 shared publicationJuan Francisco Cano‐Pérez
Endocrinology and Diabetes Unit, Hospital Universitari del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain
1 shared publicationJuan José Chillaron‐Jordan
Endocrinology and Diabetes Unit, Hospital Universitari del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain
1 shared publicationJuana Antonia Flores‐Le‐Roux
Endocrinology and Diabetes Unit, Hospital Universitari del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain
1 shared publication
Latest Publications
- 10 June 2009
- Published by Wiley in Clinical Endocrinology
- Vol. 71 (1) , 110-114
Hyperthyroidism in a population with Down syndrome (DS)
Summary: Background Thyroid disorders are frequent in patients with Down syndrome (DS). It is well‐known that the prevalence of hypothyroidism is high but data on hyperthyroidism are scarce.Objectives To assess the prevalence, aetiology, clinical characteristics, evolution and treatment of hyperthyroidism in a population with DS attending a specialized medical centre.Methods Data were gathered by systematic review of 1832 medical records from the Catalan DS Foundation, in Spain, registered between January 1991 and February 2006. Patients with the diagnosis of hyperthyroidism were identified and data on clinical features, physical examination, laboratory and imaging tests, treatment and evolution were collected.Results Twelve patients with hyperthyroidism were recorded (6·5 cases/1000 patients with DS). There were 5 males and 7 females, with a mean age at diagnosis of 16·8 years. The most common presenting symptoms were decreased heat tolerance, sweating, increased irritability and weight loss. All patients had diffuse goitre at physical examination and two patients presented with exophthalmia. Clinical diagnosis was confirmed biochemically. Thyroid‐stimulating immunoglobulin levels were raised (mean 128·1 U/l) and imaging tests confirmed the diagnosis of Graves’ disease in all cases. Patients started treatment with carbimazole at diagnosis and after a mean period of 40 months without clinical remission, they required definitive therapy with radioactive iodine. Subjects developed hypothyroidism after radio‐iodine therapy and replacement therapy with levothyroxine was necessary.Conclusions Hyperthyroidism is more prevalent in patients with DS than in the general population and has no gender predominance. It is caused mainly by Graves’ disease. Anti‐thyroid drugs were not effective in achieving remission and radioactive iodine as a definitive treatment was required in all cases.
- 10 June 2009
- Published by Wiley in Clinical Endocrinology
- Vol. 71 (1) , 110-114
Hyperthyroidism in a population with Down syndrome (DS)
Summary: Background Thyroid disorders are frequent in patients with Down syndrome (DS). It is well‐known that the prevalence of hypothyroidism is high but data on hyperthyroidism are scarce.Objectives To assess the prevalence, aetiology, clinical characteristics, evolution and treatment of hyperthyroidism in a population with DS attending a specialized medical centre.Methods Data were gathered by systematic review of 1832 medical records from the Catalan DS Foundation, in Spain, registered between January 1991 and February 2006. Patients with the diagnosis of hyperthyroidism were identified and data on clinical features, physical examination, laboratory and imaging tests, treatment and evolution were collected.Results Twelve patients with hyperthyroidism were recorded (6·5 cases/1000 patients with DS). There were 5 males and 7 females, with a mean age at diagnosis of 16·8 years. The most common presenting symptoms were decreased heat tolerance, sweating, increased irritability and weight loss. All patients had diffuse goitre at physical examination and two patients presented with exophthalmia. Clinical diagnosis was confirmed biochemically. Thyroid‐stimulating immunoglobulin levels were raised (mean 128·1 U/l) and imaging tests confirmed the diagnosis of Graves’ disease in all cases. Patients started treatment with carbimazole at diagnosis and after a mean period of 40 months without clinical remission, they required definitive therapy with radioactive iodine. Subjects developed hypothyroidism after radio‐iodine therapy and replacement therapy with levothyroxine was necessary.Conclusions Hyperthyroidism is more prevalent in patients with DS than in the general population and has no gender predominance. It is caused mainly by Graves’ disease. Anti‐thyroid drugs were not effective in achieving remission and radioactive iodine as a definitive treatment was required in all cases.
- 30 September 2008
- Published by Elsevier in Revista Clínica Española
- Vol. 208 (8) , 377-385
Riesgo cardiovascular en sujetos con alta probabilidad de síndrome metabólico y resistencia a la insulina. Estudio DESIRE
- 30 September 2008
- Published by Elsevier in Revista Clínica Española
- Vol. 208 (8) , 377-385
Riesgo cardiovascular en sujetos con alta probabilidad de síndrome metabólico y resistencia a la insulina. Estudio DESIRE